Resolution of Severe Ipilimumab-Induced Hepatitis After Antithymocyte Globulin Therapy

被引：134

作者：

Chmiel, Katarzyna D. ^{[1
,2
]}

Suan, Dan ^{[3
]}

Liddle, Christopher ^{[4
]}

Nankivell, Brian ^{[4
]}

Ibrahim, Ramy ^{[5
]}

Bautista, Charmaine ^{[6
]}

Thompson, John ^{[4
,7
]}

Fulcher, David ^{[3
,4
]}

Kefford, Richard ^{[2
,4
,7
]}

机构：

[1] Westmead Canc Care Ctr, Westmead, NSW, Australia

[2] Westmead Inst Canc Res, Westmead, NSW, Australia

[3] Westmead Hosp, Inst Clin Pathol & Med Res, Westmead, NSW 2145, Australia

[4] Univ Sydney, Sydney, NSW 2006, Australia

[5] Bristol Myers Squibb, Wallingford, CT USA

[6] i3 Asia Pacific, Singapore, Singapore

[7] Melanoma Inst Australia, Sydney, NSW, Australia

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 09期

关键词：

MONOCLONAL-ANTIBODY; MELANOMA; CTLA-4; ANTI-CTLA-4; ANTIGEN-4; EFFICACY; BLOCKADE; CANCER; TRIAL;

D O I：

10.1200/JCO.2010.32.2206

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：E237 / E240

页数：4

共 13 条

[1]

Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4 [J].

Beck, Kimberly E. ;

Blansfield, Joseph A. ;

Tran, Khoi Q. ;

Feldman, Andrew L. ;

Hughes, Marybeth S. ;

Royal, Richard E. ;

Kammula, Udai S. ;

Topalian, Suzanne L. ;

Sherry, Richard M. ;

Kleiner, David ;

Quezado, Martha ;

Lowy, Israel ;

Yellin, Michael ;

Rosenberg, Steven A. ;

Yang, James C. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) :2283-2289

[2]

A RANDOMIZED PROSPECTIVE TRIAL OF PROPHYLACTIC IMMUNOSUPPRESSION WITH ATG-FRESENIUS VERSUS OKT3 AFTER RENAL-TRANSPLANTATION [J].

BOCK, HA ;

GALLATI, H ;

ZURCHER, RM ;

BACHOFEN, M ;

MIHATSCH, MJ ;

LANDMANN, J ;

THIEL, G .

TRANSPLANTATION, 1995, 59 (06) :830-840

[3]

Chin K, 2008, ANN ONCOL, V19, P244

[4]

Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases [J].

Di Giacomo, Anna Maria ;

Danielli, Riccardo ;

Guidoboni, Massimo ;

Calabro, Luana ;

Carlucci, Dora ;

Miracco, Clelia ;

Volterrani, Luca ;

Mazzei, Maria Antonietta ;

Biagioli, Maurizio ;

Altomonte, Maresa ;

Maio, Michele .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (08) :1297-1306

[5]

CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance [J].

Friedline, Randall H. ;

Brown, David S. ;

Nguyen, Hai ;

Kornfeld, Hardy ;

Lee, JinHee ;

Zhang, Yi ;

Appleby, Mark ;

Der, Sandy D. ;

Kang, Joonsoo ;

Chambers, Cynthia A. .

JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (02) :421-434

[6]

HARMANKAYA K, MED ONCOL

[7]

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].

Hodi, F. Stephen ;

O'Day, Steven J. ;

McDermott, David F. ;

Weber, Robert W. ;

Sosman, Jeffrey A. ;

Haanen, John B. ;

Gonzalez, Rene ;

Robert, Caroline ;

Schadendorf, Dirk ;

Hassel, Jessica C. ;

Akerley, Wallace ;

van den Eertwegh, Alfons J. M. ;

Lutzky, Jose ;

Lorigan, Paul ;

Vaubel, Julia M. ;

Linette, Gerald P. ;

Hogg, David ;

Ottensmeier, Christian H. ;

Lebbe, Celeste ;

Peschel, Christian ;

Quirt, Ian ;

Clark, Joseph I. ;

Wolchok, Jedd D. ;

Weber, Jeffrey S. ;

Tian, Jason ;

Yellin, Michael J. ;

Nichol, Geoffrey M. ;

Hoos, Axel ;

Urba, Walter J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723

[8]

*NAT CANC I, IP CLIN TRIALS

[9]

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study [J].

O'Day, S. J. ;

Maio, M. ;

Chiarion-Sileni, V. ;

Gajewski, T. F. ;

Pehamberger, H. ;

Bondarenko, I. N. ;

Queirolo, P. ;

Lundgren, L. ;

Mikhailov, S. ;

Roman, L. ;

Verschraegen, C. ;

Humphrey, R. ;

Ibrahim, R. ;

de Pril, V. ;

Hoos, A. ;

Wolchok, J. D. .

ANNALS OF ONCOLOGY, 2010, 21 (08) :1712-1717

[10]

CTLA-4 Blockade with Monoclonal Antibodies in Patients with Metastatic Cancer: Surgical Issues [J].

Phan, Giao Q. ;

Weber, Jeffrey S. ;

Sondak, Vernon K. .

ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (11) :3014-3021

← 1 2 →